Finding the right tests…
Emergency services available 24 x 7
Emergency services available 24 x 7
Finding the right tests…
ELISA
This test looks for antibodies against beta-2-glycoprotein I, a blood protein that normally helps regulate clotting. It is one of three tests used to diagnose antiphospholipid syndrome, alongside lupus anticoagulant and anticardiolipin antibody, and beta-2-glycoprotein I is now considered the main target protein behind the syndrome rather than a secondary marker. Doctors order it after an unexplained clot, a stroke in someone under fifty, or repeated pregnancy loss, particularly late miscarriage or a stillbirth. Unlike the other two antiphospholipid tests, this antibody shows up on its own, without either lupus anticoagulant or anticardiolipin also being positive, in a meaningful share of people who are eventually diagnosed with antiphospholipid syndrome.
The lab reports IgG and IgM anti-beta-2-glycoprotein I levels separately, usually as a positive or negative call against that assay's own cutoff. A positive result means your immune system is producing antibodies against a protein that normally protects blood vessel linings and helps keep clotting in check - when the antibody binds this protein, it can trigger clot formation instead. Because isolated anti-beta-2-glycoprotein I positivity, without the other two antiphospholipid antibodies, has been reported in roughly a tenth to a quarter of antiphospholipid syndrome cases, doctors do not skip this test even when lupus anticoagulant and anticardiolipin come back negative.
Beta-2-glycoprotein I is now understood to be the main protein target in antiphospholipid syndrome, more so than cardiolipin itself. Antibodies against it are believed to interfere directly with the protein's normal role in regulating clot formation along blood vessel walls, which is why this test carries particular weight in diagnosis.
Antiphospholipid syndrome is defined by having at least one of three antibodies persistently positive, and anti-beta-2-glycoprotein I is the one most likely to appear by itself. Research has found this antibody alone, without lupus anticoagulant or anticardiolipin, in a notable share of confirmed cases - in one screening study of pregnant women, a small percentage carried only this antibody, and those women had a distinctly higher rate of preeclampsia than women who tested negative.
As with the other two antiphospholipid antibodies, a single positive anti-beta-2-glycoprotein I result is not enough for a diagnosis. Current criteria call for a repeat test at least twelve weeks later, since transient positives can follow infections or certain medicines without any lasting connection to clotting risk.
Both are part of the antiphospholipid antibody panel, but they target different proteins and are measured as separate results. Anti-beta-2-glycoprotein I is now considered the more central marker of the two, and it can be positive even when anticardiolipin is not.
Yes. Studies have found isolated anti-beta-2-glycoprotein I positivity, without the other two antiphospholipid antibodies, in a meaningful share of confirmed cases. That's why doctors test for all three even if one comes back negative first.
A single positive result can follow an infection or certain medicines without pointing to true antiphospholipid syndrome. Diagnostic criteria call for a second positive result at least twelve weeks later before the antibody is treated as clinically significant.
This page is general information about the test, not medical advice. Your own report's reference ranges apply — please discuss your results with your doctor.
Labs report IgG and IgM levels separately against a cutoff set by that assay. Ranges vary by lab, so check the reference value printed on your own report.
There's no fixed fasting rule tied to this specific test. Ask your doctor or the centre when you book, since instructions can change if other blood tests are drawn at the same visit.
Yes. Women who test positive for this antibody, even without other antiphospholipid antibodies, have shown a higher rate of preeclampsia in screening studies. Your doctor may recommend closer monitoring during pregnancy if the result is positive.
It can. Your doctor may recommend closer monitoring or preventive treatment during pregnancy if you test positive, particularly if you've had a previous pregnancy loss. Decisions like this are made with your obstetrician, based on your full history.